Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
1st U.S. Death From Bird Flu Reported in Louisiana
Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death
The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through North America.
Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
First U.S. Death From Bird Flu Reported in Louisiana
SOURCES: U.S. Centers for Disease Control and Prevention, health update, Jan. 6, 2025; CBS News; U.S. Centers for Disease Control and Prevention, health update, Dec. 18, 2024; Lou
1d
Why Did Moderna Stock Rise 12%?
The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.
19h
on MSN
DeSantis reasserts COVID vaccine dangers as final grand jury report finds no laws were broken
With a state grand jury report released Wednesday, Florida Gov. Ron DeSantis doubled down on the message he delivered often during the pandemic: Big Pharma deceived the public about COVID vaccines.
FiercePharma
2d
After tough year, Moderna CEO confronts challenges for RSV, COVID businesses in shareholder letter
With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...
20h
After a rough 2024, Moderna lays out plans for 2025
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...
9h
on MSN
Moderna is gambling on China as other US companies pull back
The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
6d
Moderna: From Breakthrough COVID-19 Vaccines To Personalized Cancer Therapies
Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.
floridaphoenix
1d
Statewide grand jury investigating COVID-19 vaccines finds no evidence of crimes
A statewide grand jury didn’t find evidence that COVID-19 vaccine manufacturers broke federal or state laws when making and ...
2d
Why Moderna (MRNA) Stock Is Trading Higher
Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory ...
8d
Moderna: 2025 Contrarian Play
Moderna is a contrarian play for 2025, despite a rough 2024 as one of the worst-performing Nasdaq-100 stocks. Click here to ...
Pharmaceutical Technology
3d
COVID-19 (omicron JN.1) vaccine by Moderna for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
COVID-19 (omicron JN.1) vaccine is under clinical development by Moderna and currently in Pre-Registration for Coronavirus Disease 2019 (COVID-19).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
United States
Ron DeSantis
Grand jury
NASDAQ
Novavax
Feedback